Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Woman ISDIN Vaginal Moisturizer is a non-hormonal, mucoadhesive vaginal gel-cream developed by ISDIN for the treatment of vaginal atrophy and dryness, particularly in postmenopausal women. Classified as a medical device rather than a pharmaceutical drug, it acts through a physical and mechanical moisturizing mechanism. The formulation contains glyceryl polyacrylate (polyglyceryl methacrylate) and glycerin, which together form a bioadhesive film on the vaginal mucosa to provide immediate and long-lasting hydration. This protective film helps alleviate symptoms such as itching, burning, and dyspareunia (pain during intercourse) while increasing the elasticity of the vaginal tissue. It is typically applied three times per week via single-dose applicators and is designed to be compatible with condom use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Woman ISDIN Vaginal Moisturizer (ISDIN).